Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Reinilde Heyrman > Profile

Reinilde Heyrman

Affiliations

Chief Clinical Dev. Officer at Bellerophon Therapeutics Inc. (BLPH), 2015-03-16

Insider Trading: Purchases See All

Symbol	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
BLPH	$12.00	1,500	$18,000.00	9,483	2015-02-19	Filing